Alisha Kay Taylor

Associate

About Alisha

Alisha Taylor is an associate in the Intellectual Property & Technology Practice Group, where she focuses her practice on patent prosecution and counseling, with expertise in chemical, material and pharmaceutical applications. Alisha has experience in drafting patentability and invalidity opinions, as well as performing freedom to operate analyses.

Prior to joining the firm, Alisha was a patent attorney at an intellectual property law firm in Chicago, Illinois, a business law firm in Milwaukee, Wisconsin, and a multinational law firm headquartered in Boston, Massachusetts.

Experience

  • Prosecuting patent applications for chemical applications, including polymer compositions, thermoplastic applications, catalysts, thin films and methods of synthesis.
  • Prosecuting patent applications for semiconductor technology, wire and cable applications, including nanowire semiconductors.
  • Drafting and prosecuting biotechnology applications, including single-cell tracking methods, bioassays and medical devices.
  • Prosecuting patent applications for small molecule pharmaceuticals, supplements and food additives.

Credentials

Education
  • The John Marshall Law School, J.D., 2008
  • Northwestern University, M.S., Chem., 2005
  • University of North Carolina at Chapel Hill, B.S., 2002
Admissions
  • Wisconsin, 2011
  • Illinois, 2010
  • Massachusetts, 2008
  • U.S. Patent and Trademark Office, 2006

Expertise

Services
Intellectual Property & Technology

Publications

  • Author, “Decision May Alter Future of Medical Method Patents,” Chicago Daily Law Bulletin, July 19, 2012.
  • Author, “What Does Forum Shopping in the Eastern District of Texas Mean for Patent Reform?” John Marshall Review of Intellectual Property Law, 2007.
  • Co-author, “New Magnetic Resonance Contrast Agents as Biochemical Reporters,” Current Opinion in Neurobiology, 2003.

Related insights

Global IP & Technology Law

The USPTO’s Proposed Terminal Disclaimer Rule Change: It’s Radical, But Is It Legal?

In a May 10, 2024, Notice of Proposed Rulemaking (NPRM), the USPTO proposed sweeping changes in the rules governing the filing of terminal disclaimers. If the USPTO implements the proposed changes, entire patent families could be wiped out if just one claim of one patent in the family is found invalid over prior art. Patent...… Continue Reading The post The USPTO’s Proposed Terminal Disclaimer Rule Change: It’s Radical, But Is It Legal? appeared first on Global IP & Technology Law Blog.

May 2024 | Blog

Global IP & Technology Law

Are the USPTO’s Proposed Terminal Disclaimer Fees the End of Continuing Applications?

As discussed in our previous blog (here), the United States Patent and Trademark Office’s (USPTO) has proposed substantial surcharges for filing continuing applications, depending on the timing of filing. The USPTO is also proposing substantial increases for an applicant to file a terminal disclaimer. As we discuss below, these increases are likely to affect strategies...… Continue Reading The post Are the USPTO’s Proposed Terminal Disclaimer Fees the End of Continuing Applications? appeared first on Global IP & Technology Law Blog.

April 2024 | Blog

Global IP & Technology Law

The USPTO Re-Explains What “Means” Means

On March 18, 2024, the United States Patent and Trademark Office (USPTO) issued a Memorandum containing guidance to help patent examiners analyze claim language that may be interpreted as “means-plus-function” or “step-plus-function” language under 35 U.S.C. § 112(f). The USPTO said that the Memorandum was not a change in practice for examiners. Sometimes, however, how something...… Continue Reading The post The USPTO Re-Explains What “Means” Means appeared first on Global IP & Technology Law Blog.

April 2024 | Blog

{ Category: content, LuceneQuery: +(__NodeTypeAlias:insightsitemtext __NodeTypeAlias:blogpost) -(+hideFromSearch:"1") -__NodeId:5324 +(relatedPeople:5ff080cd979240bbada625fa86176e0c) }